JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
JNCE
Delisted
JNCE was delisted on the 3rd of May, 2023.
102 hedge funds and large institutions have $120M invested in Jounce Therapeutics, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 35 increasing their positions, 32 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding in top 10
Funds holding in top 10: →
58% less capital invested
Capital invested by funds: $285M → $120M (-$165M)
Holders
102
Holding in Top 10
2
Calls
$82K
Puts
–
Top Buyers
| 1 | +$6.87M | |
| 2 | +$3.51M | |
| 3 | +$598K | |
| 4 |
Renaissance Technologies
New York
|
+$585K |
| 5 |
Invesco
Atlanta,
Georgia
|
+$543K |
Top Sellers
| 1 | -$9.51M | |
| 2 | -$5.52M | |
| 3 | -$1.51M | |
| 4 |
RI
RTW Investments
New York
|
-$976K |
| 5 |
BI
BVF Inc
San Francisco,
California
|
-$861K |